Leah Buletti

In an interview with OncLive, Ilyas Sahin, M.D., discussed milademetan in combination with imipridone ONC201 in solid tumors.

Brian Ramnaraign, M.D., is one of the Cancer Center's clinical investigators who has dedicated his career to developing better cancer treatments.

The team will study the development of a targeted therapy for an aggressive form of lung cancer.

UF researchers developed a new CRISPR-powered method for noninvasive blood tests that could help clinicians diagnose cancer at earlier stages.

The UF Health Cancer Center hosted the 15 AACR Global Scholar-in-Training Awardees on April 19-20.

The team will assess whether a new therapeutic can intercept cellular processes before pancreatic cancer develops.

The discovery could have implications for cancer, the aging process, and growth and development.

Rachel Newsome won for her research targeting the gut microbiome in lung cancer patients to improve their immune response.

The Rising Star Award recognizes exceptional early-career clinical faculty whose actions and activities consistently exemplify clinical excellence.

Two oncologists were honored for their work on clinical trials for adolescent and young adult patients with cancer.